{
    "organizations": [],
    "uuid": "5661139271dba2643539174e11dad2a0e7d4ce28",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-gtx-announced-new-data-demonstrati/brief-gtx-announced-new-data-demonstrating-enobosarms-potential-to-treat-stress-urinary-incontinence-at-sufu-2018-idUSFWN1QN0EQ",
    "ord_in_thread": 0,
    "title": "BRIEF-GTx Announced New Data Demonstrating Enobosarm's Potential To Treat Stress Urinary Incontinence At SUFU 2018",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 5 (Reuters) - GTx Inc:\n* GTX ANNOUNCED NEW DATA DEMONSTRATING ENOBOSARM’S POTENTIAL TO TREAT STRESS URINARY INCONTINENCE AT SUFU 2018\n* GTX INC - ‍TOP-LINE RESULTS FOR A PHASE 2 PLACEBO-CONTROLLED CLINICAL TRIAL EXPECTED IN SECOND HALF OF 2018​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-03-05T20:31:00.000+02:00",
    "crawled": "2018-03-06T22:21:19.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "gtx",
        "inc",
        "gtx",
        "announced",
        "new",
        "data",
        "demonstrating",
        "enobosarm",
        "potential",
        "treat",
        "stress",
        "urinary",
        "incontinence",
        "sufu",
        "gtx",
        "inc",
        "result",
        "phase",
        "clinical",
        "trial",
        "expected",
        "second",
        "half",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}